Consistent with previous findings [29], the frequency of CD19+ B cells was increased in early RA patients when compared with healthy controls (p < 0.05) and showed an elevated trend in RA-risk individuals when compared to healthy controls (Figure 3A). Here, CD19 is linked to rheumatoid arthritis.